PHARVARIS N V PHVS
COM · Common Stock · CUSIP N69605108
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 52.3m as of 2023-12-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $28.05.
Trends to Q4 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 22 |
| Q4 2022 | 26 |
| Q1 2023 | 22 |
| Q2 2023 | 22 |
| Q3 2023 | 22 |
| Q4 2023 | 37 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 14 | 8 |
| Q1 2023 | 6 | 9 |
| Q2 2023 | 10 | 7 |
| Q3 2023 | 9 | 9 |
| Q4 2023 | 29 | 7 |
Biggest buyers
| FMR LLC | Added | +2.0m |
| Venrock Adviser, LLC | Added | +1.8m |
| GENERAL ATLANTIC, L.P. | Added | +1.8m |
| EcoR1 Capital, LLC | New | +900.0k |
| PRICE T ROWE ASSOCIATES INC /MD/ | New | +842.7k |
| DEERFIELD MANAGEMENT COMPANY, L.P. | New | +812.2k |
| Commodore Capital LP | New | +800.0k |
| venBio Partners LLC | Added | +654.8k |
| Sofinnova Investments, Inc. | New | +510.4k |
| VIKING GLOBAL INVESTORS LP | Added | +425.0k |
Biggest sellers
| Bain Capital Life Sciences Investors, LLC | Reduced | -880.4k |
| Soleus Capital Management, L.P. | Reduced | -126.6k |
| Foresite Capital Management V, LLC | Sold out | -33.1k |
| Y-Intercept (Hong Kong) Ltd | Sold out | -17.6k |
| Hudson Bay Capital Management LP | Reduced | -7.7k |
| Walleye Capital LLC | Reduced | -3.1k |
| UBS Group AG | Sold out | -50 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| GENERAL ATLANTIC, L.P. 13G · passive investor filed 2026-08-14 | 7.6% |
| VIKING GLOBAL INVESTORS LP 13G · passive investor filed 2026-05-15 | 5.6% |
Fell to 5% or below in the last year: LSP V Cooperatieve U.A. (4.9%, 2026-07-31), Bain Capital Life Sciences Fund, L.P. (2.5%, 2026-02-17)
Insider purchases and sales in Q4 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2023.
Holders, Q4 2023
| Manager | Shares | Change |
|---|---|---|
| GENERAL ATLANTIC, L.P. 2.48% of their portfolio | 6.2m $172.7m | Added +1.8m |
| FMR LLC 0.01% of their portfolio | 5.2m $145.7m | Added +2.0m |
| venBio Partners LLC 20.68% of their portfolio | 4.9m $138.0m | Added +654.8k |
| Foresite Capital Management IV, LLC 57.25% of their portfolio | 4.0m $113.3m | Added +295.4k |
| Bain Capital Life Sciences Investors, LLC 10.50% of their portfolio | 3.9m $109.5m | Reduced -880.4k |
| VIKING GLOBAL INVESTORS LP 0.38% of their portfolio | 3.7m $102.6m | Added +425.0k |
| Venrock Adviser, LLC 6.53% of their portfolio | 3.4m $95.2m | Added +1.8m |
| Cormorant Asset Management, LP 2.30% of their portfolio | 1.7m $48.0m | Added +350.0k |
| NOVO HOLDINGS A/S 2.67% of their portfolio | 1.5m $43.2m | Added +210.0k |
| EcoR1 Capital, LLC 0.66% of their portfolio | 900.0k $25.2m | New |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 842.7k $23.6m | New |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.42% of their portfolio | 812.2k $22.8m | New |
| Commodore Capital LP 1.96% of their portfolio | 800.0k $22.4m | New |
| 5AM Venture Management, LLC 5.93% of their portfolio | 797.6k $22.4m | Added +210.0k |
| Sofinnova Investments, Inc. 0.80% of their portfolio | 510.4k $14.3m | New |
| Vivo Capital, LLC 0.65% of their portfolio | 285.0k $8.0m | New |
| SPHERA FUNDS MANAGEMENT LTD. 1.28% of their portfolio | 245.0k $6.9m | New |
| Soleus Capital Management, L.P. 0.68% of their portfolio | 217.4k $6.1m | Reduced -126.6k |
| MILLENNIUM MANAGEMENT LLC 0.01% of their portfolio | 188.5k $5.3m | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 141.5k $4.0m | New |
| Blackstone Inc. 0.01% of their portfolio | 100.0k $2.8m | New |
| Walleye Capital LLC 0.03% of their portfolio | 77.9k $2.2m | Reduced -3.1k |
| Hudson Bay Capital Management LP 0.02% of their portfolio | 70.1k $2.0m | Reduced -7.7k |
| MARSHALL WACE, LLP 0.00% of their portfolio | 60.1k $1.7m | New |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio | 55.1k $1.5m | New |
| MORGAN STANLEY 0.00% of their portfolio | 45.0k $1.3m | Added +11.3k |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 32.3k $906.5k | Added +29.7k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 21.6k $605.7k | Unchanged |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.02% of their portfolio | 18.0k $504.9k | Not comparable |
| Schonfeld Strategic Advisors LLC 0.00% of their portfolio | 12.4k $347.8k | Added +500 |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 8.5k $239.8k | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 8.2k $230.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 2.3k $63.6k | Unchanged |
| Quarry LP 0.01% of their portfolio | 750 $21.0k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 380 $10.7k | New |
| PIPER SANDLER & CO. 0.00% of their portfolio | 181 $5.1k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |